FDC Limited

Web: fdcindia.com NSE: FDC BSE: 531599 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

400 10(-3%)

Volume

10L as on 23, Jun

Open

502

High

506

Low

500

410

VWAP

412

52 Week High

528

52 Week Low

313

Viand Research Rating

Quality Score

57/100

Growth Score

21/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

6,512

No. of Shares

16.3

P/E

26.57

P/B

3.67

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

13.8

ROCE

Profit Growth

Listing Date

07-Aug-97

Promoter Holding

69.65%

FII Holding

2.4%

DII Holding

6.29%

Price Chart

Price Performance

1 Week7%

1 Month10%

3 Months26%

6 Months14%

1 Year14%

YTD14%

Moving Average

5 Day SMA394

10 Day SMA389

20 Day SMA393

30 Day SMA385

50 Day SMA377

61 Day SMA369

80 Day SMA525

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	431	409	419	440
Resistance 2	419	407	411	423
Resistance 1	411	405	407	420
Pivot Point	399	404	399	403
Support 1	391	402	392	400
Support 2	379	400	387	384
Support 3	372	398	379	380

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 69.65%	(0.01) 69.66%	(0.01) 69.66%	(0.01) 69.66%	(0.01) 69.66%	(0.01) 69.66%	(0.01) 69.66%	(0.01) 69.66%	(0.01) 69.66%	(0.01) 69.66%	(0.21) 69.66%	(0.01) 69.49%	(0.01) 69.49%	(0.01) 69.49%	(0.01) 69.49%	(0.11) 69.50%	(0.01) 69.36%	(0.01) 69.36%	(0.01) 69.35%
FIIs	(0.11) 2.40%	(-0.11) 2.32%	(0.01) 2.43%	(-0.21) 2.41%	(-0.11) 2.56%	(0.01) 2.67%	(0.11) 2.62%	(-0.11) 2.51%	(0.21) 2.65%	(0.01) 2.43%	(0.41) 2.42%	(-1.71) 2.06%	(0.01) 3.80%	(-0.21) 3.77%	(-0.41) 3.99%	(-0.21) 4.34%	(0.01) 4.52%	(0.01) 4.47%	(0.01) 4.51%
DIIs	(0.01) 6.29%	(-0.51) 6.27%	(-0.41) 6.81%	(0.81) 7.17%	(0.31) 6.37%	(0.11) 6.08%	(-0.71) 6.02%	(-0.21) 6.72%	(-0.81) 6.94%	(-0.41) 7.76%	(-1.01) 8.12%	(0.91) 9.13%	(0.51) 8.27%	(1.01) 7.76%	(0.71) 6.77%	(0.21) 6.07%	(0.41) 5.86%	(0.81) 5.46%	(0.01) 4.65%
Public	21.65%	21.76%	21.10%	20.76%	21.42%	21.60%	21.71%	21.11%	20.76%	20.15%	19.80%	19.32%	18.44%	18.98%	19.75%	20.09%	20.27%	20.72%	21.48%
No. of Shareholders	52,730	53,788	54,157	54,445	53,880	55,228	55,400	50,634	52,377	55,341	56,928	56,717	57,012	59,871	63,172	65,318	86,503	53,582	49,889

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	585	465	473	648	492	464	514	638	462	458	486	536	435	409	445	495	341	342	398	447
Sales Growth % (YoY)	18.9%	0.1%	-7.9%	1.6%	6.5%	1.3%	5.6%	19%	6.3%	11.9%	9.3%	8.4%	27.5%	19.8%	11.9%	10.6%	8.8%	0.5%	7.1%	45.2%
Sales Growth % (QoQ)	25.8%	-1.7%	-27%	31.7%	6%	-9.7%	-19.4%	38.1%	0.9%	-5.8%	-9.3%	23.2%	6.4%	-8.1%	-10.1%	45.2%	-0.3%	-14.1%	-11%	-
Expenses	478	412	439	508	438	417	444	492	406	374	410	414	386	360	378	417	322	294	326	332
Operating Profit	106	52	34	140	54	47	70	147	56	84	76	122	49	49	67	78	19	48	71	115
OPM %	18	11	7	22	11	10	14	23	12	18	16	23	11	12	15	16	6	14	18	26
Other Income	50	0	21	36	16	19	35	28	20	25	27	29	7	18	13	19	10	13	30	23
Interest	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Depreciation	14	15	15	15	16	13	14	11	10	10	10	10	10	10	10	9	9	9	9	10
Profit before tax	140	36	38	160	53	51	90	163	65	98	93	141	45	57	69	87	19	51	91	128
Tax %	26	22	26	24	27	28	20	27	29	19	25	22	32	28	25	19	45	30	21	24
Net Profit	103	28	28	121	39	37	72	119	46	79	70	110	31	41	52	71	10	36	72	98
Net Profit Growth % (QoQ)	267.9%	-	-76.9%	210.3%	5.4%	-48.6%	-39.5%	158.7%	-41.8%	12.9%	-36.4%	254.8%	-24.4%	-21.2%	-26.8%	610%	-72.2%	-50%	-26.5%	-
Net Profit Growth % (YoY)	164.1%	-24.3%	-61.1%	1.7%	-15.2%	-53.2%	2.9%	8.2%	48.4%	92.7%	34.6%	54.9%	210%	13.9%	-27.8%	-27.6%	-	-	-	-
TTM Net Profit	280	216	225	269	267	274	316	314	305	290	252	234	195	174	169	189	216	206	170	0
EPS in Rs	6.35	1.74	1.74	7.45	2.38	2.28	4.42	7.31	2.84	4.87	4.29	6.62	1.85	2.46	3.12	4.26	0.62	2.11	4.29	5.8

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2171	2108	1943	1784	1525	1331	1341	1089	1074	1013	994	888	845	772
Sales Growth %	-	8.5%	8.9%	17%	14.6%	-0.8%	23.2%	1.4%	6%	1.9%	11.8%	5.1%	9.5%	8.8%
Expenses	1825	1783	1604	1533	1271	997	1038	860	841	769	765	690	638	591
Operating Profit	346	325	339	251	254	334	304	229	233	243	229	199	207	181
OPM %	16	15	17	14	17	25	23	21	22	24	23	22	24	23
Other Income	93	91	102	50	76	95	57	42	45	44	39	46	39	46
Interest	5	5	4	4	3	3	3	1	1	1	1	2	3	2
Depreciation	59	54	40	39	37	38	37	33	35	35	34	39	25	28
Profit before tax	375	357	396	258	289	388	320	237	241	252	232	204	218	198
Tax %	25	25	23	25	25	22	25	28	28	25	27	27	38	22
Net Profit	281	267	305	194	216	301	240	170	174	189	169	148	135	155
Net Profit Growth %	5.2%	-12.5%	57.2%	-10.2%	-28.2%	25.4%	41.2%	-2.3%	-7.9%	11.8%	14.2%	9.6%	-12.9%	-
EPS in Rs	17.29	16.39	18.75	11.7	12.82	17.85	14.03	9.74	9.95	10.6	9.48	8.33	7.61	8.49
Dividend Payout %	29	31	0	0	0	0	6	0	0	21	24	27	30	26

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	318	221	155	162	207	250	112	150	154	174	128	150	150
Cash from Investing Activity	-199	-17	11	-145	-77	-98	-121	21	-144	-73	-89	-55	-107
Cash from Financing Activity	-92	-202	-180	-10	-129	-142	0	-169	0	-97	-48	-75	-63
Net Cash Flow	26	2	-14	7	1	10	-8	1	11	4	-9	19	-20

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	16	16	16	16	17	17	17	17	18	18	18	18	18	18	18
Reserves	2415	2265	2275	2081	1965	1940	1717	1530	1428	1259	1252	1065	919	827	766
Borrowings	21	21	20	21	28	32	15	15	1	1	1	1	2	3	3
Other Liabilities	433	412	376	350	333	281	207	250	194	228	197	182	210	211	179
Total Liabilities	2886	2714	2688	2468	2343	2270	1956	1813	1640	1505	1468	1266	1148	1059	966
Fixed Assets	842	852	805	680	699	705	689	674	682	674	678	675	393	284	289
CWIP	163	137	143	261	198	105	19	24	12	13	6	20	29	18	7
Investments	1007	1028	1066	843	806	886	790	665	585	471	491	325	489	417	416
Other Assets	874	698	674	684	640	575	458	451	360	348	293	246	237	340	254
Total Assets	2886	2714	2688	2468	2343	2270	1956	1813	1640	1505	1468	1266	1148	1059	966

Delivery

#	Date	354 25% 442	Value (Cr)	Q/T 33	Del 52	Del 28
1	22-Jul	410	6	17	41	2
2	21-Jul	413	4	19	62	2
3	20-Jul	418	3	14	53	2
4	17-Jul	420	4	13	57	2
5	16-Jul	422	5	25	59	3
6	15-Jul	424	2	12	54	1
7	14-Jul	422	3	9	53	2
8	13-Jul	428	5	20	51	2
9	10-Jul	432	7	15	53	4
10	9-Jul	432	14	33	50	7
11	8-Jul	423	10	28	50	5
12	7-Jul	426	5	14	60	3
13	6-Jul	430	5	26	53	3
14	3-Jul	434	9	34	60	5
15	2-Jul	434	10	27	53	5
16	1-Jul	431	11	22	57	6
17	30-Jun	424	21	26	51	11
18	29-Jun	421	16	32	54	8
19	25-Jun	408	9	25	48	4
20	24-Jun	411	17	25	44	7
21	23-Jun	412	42	36	44	18
22	22-Jun	404	18	32	46	8
23	19-Jun	389	5	24	48	3
24	18-Jun	384	5	18	58	3
25	17-Jun	381	3	15	67	2
26	16-Jun	384	4	14	53	2
27	15-Jun	385	8	27	52	4
28	12-Jun	388	10	23	41	4
29	11-Jun	379	5	15	50	3
30	10-Jun	381	7	16	50	4
31	9-Jun	394	11	19	51	6
32	8-Jun	381	13	27	37	5
33	5-Jun	381	24	35	45	11
34	4-Jun	401	40	35	37	15
35	3-Jun	399	20	26	44	9
36	2-Jun	393	21	31	56	12
37	1-Jun	395	18	25	53	9
38	29-May	405	99	37	56	55
39	27-May	430	119	57	30	35
40	26-May	403	77	43	29	22
41	25-May	369	10	21	67	7
42	22-May	373	14	20	53	7
43	21-May	362	6	11	63	4
44	20-May	364	3	16	67	2
45	19-May	363	4	31	75	3
46	18-May	362	5	12	36	2
47	15-May	366	2	17	43	1
48	14-May	369	2	19	53	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	6,512c	180c	2.69
22-Jul	6,692c	0	0
21-Jul	6,692c	114c	1.67
17-Jul	6,806c	65c	0.95
16-Jul	6,871c	30c	0.44
15-Jul	6,901c	81L	0.01
14-Jul	6,900c	89c	1.27
13-Jul	6,989c	87c	1.23
10-Jul	7,076c	47c	0.67
09-Jul	7,029c	147c	2.13
08-Jul	6,882c	63c	0.90
07-Jul	6,945c	56c	0.80
06-Jul	7,001c	3c	0.05
02-Jul	6,998c	11c	0.16
01-Jul	7,009c	81c	1.18
30-Jun	6,928c	136c	2.00
29-Jun	6,792c	152c	2.29
26-Jun	6,639c	36c	0.54
25-Jun	6,675c	2c	0.02
24-Jun	6,677c	112c	1.65
23-Jun	6,789c	164c	2.48
22-Jun	6,625c	267c	4.20
19-Jun	6,358c	155c	2.49
17-Jun	6,203c	46c	0.74
16-Jun	6,250c	25c	0.40
15-Jun	6,275c	37c	0.59
12-Jun	6,312c	90c	1.45
11-Jun	6,222c	84c	1.33
10-Jun	6,306c	0	0

Stock Checklist

Price is below from 52 week high low average: 19%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 27 fund scheme(s) across 8 fund house(s) as of Jul26 · Total value ₹852 Cr · 9 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
ICICI Prudential Mutual Fund	12	1.29%	+0.08%	383.1
Nippon India Mutual Fund	2	0.21%	-	311.6
ICICI Prudential Asset Management Company Limited	1	0.78%	+0.78%	73.3
Tata Mutual Fund	2	1.94%	-	51.3
Bandhan Mutual Fund	4	0.10%	-	32.6
Motilal Oswal Mutual Fund	2	0.01%	-	0
Angel One Mutual Fund	2	0.00%	-	0
Mirae Asset Mutual Fund	2	0.00%	-	0

FDC Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements